Adaptive vasopressor control, from decision support to full autonomy.
E-Fusion is in development and has not been evaluated in human clinical studies. It is not available for sale or clinical use.
In sepsis, major trauma, and high-risk surgery, titrating vasopressors demands constant bedside vigilance, and even small delays matter.
E-Fusion pairs physiological modeling with adaptive control to track a patient's evolving condition and adjust therapy in real time, spanning a range from decision support to full closed-loop autonomy.